Physician profile
Alan E Leifeste
NPI 1700988714
$2,745.47
in general payments reported to CMS, 2019-2025
18 companies · $995 in 2025
The $995 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.16 · 2020: $41.50 · 2021: $361 · 2022: $244 · 2023: $332 · 2024: $700 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,026.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,241.53 | 2020-2025 | Otezla, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.68 | 2023-2025 | Jardiance |
| Medtronic, INC. | $232.27 | 2021 | |
| Globus Medical, INC. | $174.82 | 2025 | Creo |
| Astrazeneca Pharmaceuticals LP | $166.56 | 2024-2025 | Airsupra |
| Inspire Medical Systems, INC. | $145.67 | 2025 | Inspire |
| Genzyme Corporation | $124.14 | 2024 | |
| Teleflex LLC | $110.93 | 2025 | Barrigel |
| Johnson & Johnson Surgical Vision, INC. | $77.65 | 2024 | Tecnis Simplicity |
| Sunovion Pharmaceuticals INC. | $40.33 | 2019 | |
| Dexcom, INC. | $37.98 | 2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $34.59 | 2025 | The Cologuard Plus Collection Kit |
| Abbott Laboratories | $24.85 | 2020 | |
| Astellas Pharma US INC | $18.76 | 2023 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $17.20 | 2024 | Eohilia |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $16.96 | 2019 | |
| Amneal Pharmaceuticals LLC | $15.68 | 2022 | |
| Novo Nordisk INC | $14.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Leifeste listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.